Search by Drug Name or NDC
NDC 00641-6046-10 Lorazepam 2 mg/mL Details
Lorazepam 2 mg/mL
Lorazepam is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is LORAZEPAM.
Product Information
NDC | 00641-6046 |
---|---|
Product ID | 0641-6046_2297cbcd-0026-412e-8186-1816b34c1d67 |
Associated GPIs | 57100060002005 |
GCN Sequence Number | 003755 |
GCN Sequence Number Description | lorazepam VIAL 2 MG/ML INJECTION |
HIC3 | H21 |
HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
GCN | 14140 |
HICL Sequence Number | 004846 |
HICL Sequence Number Description | LORAZEPAM |
Brand/Generic | Generic |
Proprietary Name | Lorazepam |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Lorazepam |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAMUSCULAR; INTRAVENOUS |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/mL |
Substance Name | LORAZEPAM |
Labeler Name | Hikma Pharmaceuticals USA Inc. |
Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
DEA Schedule | CIV |
Marketing Category | NDA |
Application Number | NDA018140 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00641-6046-10 (00641604610)
NDC Package Code | 0641-6046-10 |
---|---|
Billing NDC | 00641604610 |
Package | 10 VIAL in 1 CARTON (0641-6046-10) / 10 mL in 1 VIAL (0641-6046-01) |
Marketing Start Date | 1980-07-25 |
NDC Exclude Flag | N |
Pricing Information | N/A |